Comprehensive Financial Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.7M Hold
26,273
0.09% 24
2026
Q1
$1.25M Hold
26,273
0.04% 27
2025
Q4
$833K Hold
26,273
0.03% 30
2025
Q3
$739K Hold
26,273
0.02% 32
2025
Q2
$967K Hold
26,273
0.03% 34
2025
Q1
$1.03M Hold
26,273
0.03% 28
2024
Q4
$1.22M Hold
26,273
0.03% 28
2024
Q3
$1.19M Hold
26,273
0.03% 29
2024
Q2
$1.29M Hold
26,273
0.05% 27
2024
Q1
$901K Hold
26,273
0.03% 29
2023
Q4
$968K Hold
26,273
0.03% 29
2023
Q3
$532K Hold
26,273
0.02% 35
2023
Q2
$538K Hold
26,273
0.02% 37
2023
Q1
$396K Hold
26,273
0.01% 41
2022
Q4
$626K Hold
26,273
0.02% 38
2022
Q3
$926K Hold
26,273
0.02% 37
2022
Q2
$919K Hold
26,273
0.03% 36
2022
Q1
$1.3M Hold
26,273
0.02% 36
2021
Q4
$2.03M Hold
26,273
0.03% 32
2021
Q3
$2.81M Hold
26,273
0.03% 27
2021
Q2
$3.5M Hold
26,273
0.03% 24
2021
Q1
$3.25M Sell
26,273
-16,090
-38% -$2.44M 0.03% 19
2020
Q4
$5.99M Hold
42,363
0.06% 14
2020
Q3
$3.22M Hold
42,363
0.04% 15
2020
Q2
$1.92M Hold
42,363
0.02% 18
2020
Q1
$1.29M Hold
42,363
0.03% 18
2019
Q4
$890K Buy
+42,363
New +$991K 0.02% 18

Other funds holding TWST

Comprehensive Financial Management's TWST Position: Q2 2026 in Review

Comprehensive Financial Management held its Twist Bioscience (TWST) position steady in Q2 2026 at 26,273 shares worth $2.7M. The position accounts for 0.09% of the portfolio, ranked #24.

Comprehensive Financial Management first reported a position in TWST in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.99M in Q4 2020. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Comprehensive Financial Management held 26,273 shares of Twist Bioscience worth $2.7M as of Q2 2026.
  • Comprehensive Financial Management left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up 0.09% of Comprehensive Financial Management's portfolio in Q2 2026, its #24 holding.
  • Comprehensive Financial Management first reported a position in Twist Bioscience in Q4 2019 and has held it in 27 quarters since.
  • Comprehensive Financial Management's Twist Bioscience position peaked at $5.99M in Q4 2020.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Comprehensive Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.